Correlation Between Aquestive Therapeutics and Pacira BioSciences,

Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Pacira BioSciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Pacira BioSciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aquestive Therapeutics and Pacira BioSciences,, you can compare the effects of market volatilities on Aquestive Therapeutics and Pacira BioSciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Pacira BioSciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Pacira BioSciences,.

Diversification Opportunities for Aquestive Therapeutics and Pacira BioSciences,

-0.46

Correlation Coefficient

Aquestive Therapeutics  Pacira BioSciences,

Very good diversification

The 3 months correlation between Aquestive and Pacira is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Pacira BioSciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacira BioSciences, and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Pacira BioSciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacira BioSciences, has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Pacira BioSciences, go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and Pacira BioSciences,

Given the investment horizon of 90 days Aquestive Therapeutics is expected to under-perform the Pacira BioSciences,. In addition to that, Aquestive Therapeutics is 1.52 times more volatile than Pacira BioSciences,. It trades about -0.04 of its total potential returns per unit of risk. Pacira BioSciences, is currently generating about 0.17 per unit of volatility. If you would invest  1,894  in Pacira BioSciences, on December 30, 2024 and sell it today you would earn a total of  597.00  from holding Pacira BioSciences, or generate 31.52% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Aquestive Therapeutics  vs.  Pacira BioSciences,

Aquestive Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aquestive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pacira BioSciences,

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Pacira BioSciences, are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Pacira BioSciences, showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aquestive Therapeutics and Pacira BioSciences,

The main advantage of trading using opposite Aquestive Therapeutics and Pacira BioSciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Pacira BioSciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacira BioSciences, will offset losses from the drop in Pacira BioSciences,'s long position.

The idea behind Aquestive Therapeutics and Pacira BioSciences, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.